T-Cell Subsets and Interleukin-10 Levels Are Predictors of Severity and Mortality in COVID-19: A Systematic Review and Meta-Analysis

Amal F Alshammary; Jawaher M Alsughayyir; Khalid K Alharbi; Abdulrahman M Al-Sulaiman; Haifa F Alshammary; Heba F Alshammary

doi:10.3389/fmed.2022.852749

T-Cell Subsets and Interleukin-10 Levels Are Predictors of Severity and Mortality in COVID-19: A Systematic Review and Meta-Analysis

Front Med (Lausanne). 2022 Apr 28:9:852749. doi: 10.3389/fmed.2022.852749. eCollection 2022.

Authors

Amal F Alshammary¹, Jawaher M Alsughayyir¹, Khalid K Alharbi¹, Abdulrahman M Al-Sulaiman², Haifa F Alshammary³, Heba F Alshammary⁴

Affiliations

¹ Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
² Department of Medical and Molecular Virology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
³ College of Applied Medical Sciences, Riyadh Elm University, Riyadh, Saudi Arabia.
⁴ College of Dentistry, Riyadh Elm University, Riyadh, Saudi Arabia.

Abstract

Background: Many COVID-19 patients reveal a marked decrease in their lymphocyte counts, a condition that translates clinically into immunodepression and is common among these patients. Outcomes for infected patients vary depending on their lymphocytopenia status, especially their T-cell counts. Patients are more likely to recover when lymphocytopenia is resolved. When lymphocytopenia persists, severe complications can develop and often lead to death. Similarly, IL-10 concentration is elevated in severe COVID-19 cases and may be associated with the depression observed in T-cell counts. Accordingly, this systematic review and meta-analysis aims to analyze T-cell subsets and IL-10 levels among COVID-19 patients. Understanding the underlying mechanisms of the immunodepression observed in COVID-19, and its consequences, may enable early identification of disease severity and reduction of overall morbidity and mortality.

Methods: A systematic search was conducted covering PubMed MEDLINE, Scopus, Web of Science, and EBSCO databases for journal articles published from December 1, 2019 to March 14, 2021. In addition, we reviewed bibliographies of relevant reviews and the medRxiv preprint server for eligible studies. Our search covered published studies reporting laboratory parameters for T-cell subsets (CD4/CD8) and IL-10 among confirmed COVID-19 patients. Six authors carried out the process of data screening, extraction, and quality assessment independently. The DerSimonian-Laird random-effect model was performed for this meta-analysis, and the standardized mean difference (SMD) and 95% confidence interval (CI) were calculated for each parameter.

Results: A total of 52 studies from 11 countries across 3 continents were included in this study. Compared with mild and survivor COVID-19 cases, severe and non-survivor cases had lower counts of CD4/CD8 T-cells and higher levels of IL-10.

Conclusion: Our findings reveal that the level of CD4/CD8 T-cells and IL-10 are reliable predictors of severity and mortality in COVID-19 patients. The study protocol is registered with the International Prospective Register of Systematic Reviews (PROSPERO); registration number CRD42020218918.

Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020218918, identifier: CRD42020218918.

Keywords: CD4; CD8; COVID-19; IL-10; SARS-CoV-2; coronavirus; interleukin 10.

Publication types

Systematic Review